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Abstract
Periodontal disease, a common inflammatory oral disease involved periodontal tissues, has been linked with
the evidence of some systemic disorders.  Recently, periodontal disease has been suspected as a trigger of
systemic disorders. Penetration of bacterial products, such as lipopolysaccharide (LPS) may reach into deeper
periodontal tissues. Therefore there may affect systemic blood and cytokines production. Interleukin-1β (IL-
1β) and Tumour Nuclear Factor-α (TNF-α) are known as pro-inflammatory cytokines. The production of
systemic IL-1β and TNF-α of E. coli lipopolysaccharide-induced periodontitis model on rats was investigated
in this research. Fifteen male Wistar rats, aged 6-8 weeks used for this study were divided into 3 groups. For
group 1 and 2, silk ligature 3/0 were inserted in interdental area between upper right molar 1 and 2. First and
second group received solution containing 10µg/ml and 1mg/ml E. coli lipopolysaccharide, respectively, mixed
with 2% carboxymethylcellulose (CMC) diluted in 100µl of phosphate buffer saline (PBS). The solution was
topically applied on gingival tissues around the gingival sulcus, a single topical application of solution once
per 2 days for 14 days. Untreated subjects were used as negative control. On day 15, the blood was collected
from vena orbitalis, and rats were sacrificed. The blood serum of each group was divided into 2 groups and
cultured for 4 hours with or without 20µl of 100ng/ml of E. coli LPS. ELISA techniques were used to measure
the cytokine productions of the supernatant. The data was analysed using Repeated Measure ANOVA. This
study showed that there was a significant increase of IL-1β production on low dose of LPS compared to
control and high dose of LPS groups (p<0.05). Whereas TNF-α not significantly showed increasing trend. The
increasing trend of pro-inflammatory cytokine productions, such as IL-1β and TNF-α, on LPS-induced
periodontitis model in this experiment supports the previous studies about the contribution of periodontal
disease in the pathogenesis of systemic diseases.
Keywords:  IL-1β, TNF-α , E. coli LPS, rat’s periodontitis model
* This article has been presented orally in 5th FDI-IDA Joint
Meeting, Bali-Indonesia, on 14-15 November 2009.
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1. Introduction
Periodontitis is a chronic inflammatory disease
affecting periodontal tissues1. The progress of this
disease is multifactorial and often caused by the
interaction between specific bacterial infections and
the host immune responses. At early periodontitis
stages, the lesions are characterized by the migration
of leucocytes into the gingival sulcus, loss of the
collagen fiber network and proliferation of basal cells
in the junctional epithelium. At advance stages,
bacteria and bacterial products act on inflammatory
cells inducing production of various inflammatory
mediators and cytokines leading to destruction of the
organ supporting the teeth, including soft tissues and
bone, either directly or indirectly 2,3.
A major part of the outer membrane of gram-
negative bacteria (lipopolysaccharide / LPS) is the
most potent imunostimulator in mamals that induces
the synthesis of cytokines such as interleukin-1 (IL-
1) and tumor necrosis factor (TNF) from
macrophages, fibroblasts, and endothelial cells 4. It
is widely accepted that LPS penetrates deeper in the
periodontal tissues, recruits and activates immune
cells5. The elevation of IL-1, and TNF productions has
been detected in the gingival crevicular fluid and
inflamed gingiva of patients with periodontal
disease2,6. These cytokines appear to play a central
role in the pathogenesis of inflammatory periodontal
diseases. The application of E. coli LPS into the rat
gingival sulcus induces the production of pro-
inflammatory cytokines such as TNF-α, IL-1α and IL-
1β7.
The relationship between poor oral health
condition, particularly periodontal disease and
systemic disorders has been extensively investigated.
Recent studies suggest that this relationship may
exist, which periodontal disease may trigger the
initiation of several systemic diseases or conditions,
such as diabetes mellitus, atherosclerosis and
pulmonary disease, lung disease, osteoporosis and
preterm low birth weight infants8. Munford9 has
shown that the trace of [3H]LPS  has been found in
spleen, liver, adrenal gland, and lung, 10 minutes
after an intravenous injection of LPS on rat.
Therefore, it is predicted that the local LPS induction
on bone jaw may also affect systemically including
some internal organs and blood system. However,
at this stage, the exact mechanism remains unclear.
Cytokines are small polypeptides with a wide
spectrum of inflammatory, hemopoietic, metabolic
and immunomodulatory properties. Comparable to
bacterial infection, bacterial lipopolysaccharide is the
potent immunostimulator that can induce acute
inflammatory responses10. They are produced by a
variety of cells, including blood cells. As a
consequence, cytokines and their receptors form a
network of high complexity that is under tight but
complex biological control, including positive and
negative feedback by the cytokines themselves.
LPS-stimulated blood cell have been used to
investigate potential differences in immune
capacity11,12. Blood monocytes become activated by
the LPS and release pro-inflammatory cytokines and
prostaglandins. IL-1β plays a major role in acute and
chronic inflammation and is secreted mainly by blood
macrophages13. Another important inflammation
marker in blood serum is TNF-α10. LPS from gram-
negative bacteria are potent TNF-α inducers. The
peak of circulating TNF occurs rapidly within 90 min
after LPS or bacteria injection and The TNF-α peak
occurs before of IL-1, IL-6, and IL-8. Other study
revealed that TNF-α mRNA levels peak in vivo at 15
min after LPS injection and at 1 hr in in vitro assays14.
This study is to investigate the level of IL-1β and TNF-
α from ex vivo whole blood culture of E. coli
lipopolysaccharide-induced periodontitis model on
rats.
2. Materials and Methods
Male wistar rats (6-8 weeks old, 200-250 grams) were
purchased from LPPT Universitas Gadjah Mada were
used in all studies. Purified E coli serotype O55:B5
lipopolysaccharide (phenol-extract) was purchased
from Sigma Chemical Co. Ten mg/ml or 1mg/ml of
E. coli LPS were mixed with 2% carboxymethylcellulose
sodium salt high viscosity (MP Biomedicals, Inc) and
diluted in 1 ml of phosphate buffer saline (PBS) to
make a thick solution. Rat ELISA Kit for TNF-α and IL-
1β were purchased from Bender MedSystem.
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2.1. Periodontitis model
The model of periodontitis done in this research was
the modification of  Hasturk’s method15. Briefly, a
total of 15 male wistar rats were divided into three
groups: two treated groups and control group. Under
general anaesthesia (50-75mg/kg of Zolethyl, Virbac
Lab., France; IM injection) rats were fixed on his back.
Ten rats were treated by inserting silk ligature 3/0 in
the interdental area between upper right molar 1 and
2. Fifty ml of LPS slurry solution was then topically
applied to the gingival tissues around the gingival
sulcus, a single topical application of solution once
per 2 days for 14 days. The ligatures were checked at
every application and lost ligatures were replaced.
Untreated subjects were used as negative control.
On day 15, under the anaesthesia, the blood was
withdrawn from vena orbitalis into 3ml EDTA
containing tube (Becton Dickinson Vacutainer
System, Franklin Lakes, NJ, USA) and rats were
sacrificed. The experimental protocol has been
approved by Ethics Committee.
2.2. Ex-vivo culture
Whole blood (990ml) was diluted 1:1 with RPMI 1640
(Sigma Chemical Co.) containing 25mM HEPES, 100
U/ml benzylpenicillin, dan 100 µg /ml of
streptomycin. The mixtures were set up in 24 flat-
bottomed plates (Iwaki, Japan).  Cultures were
incubated with or without 20µl of 100ng/ml E. coli
LPS for 4 hours at 37oC in a 5% CO
2
. After
centrifugation, supernatants were collected and
stored at -80°C until cytokine determination. ELISA
techniques were used to measure the cytokine
productions of the supernatant according to the
manufacture’s instructions. The data was analysed
using Repeated Measure ANOVA.
3. Results and Discussion
In vivo periodontitis model reflected initial LPS
challenge which was done by inserting silk ligature
3/0 in the molar interdental area followed by topical
application of 10µg/ml or 1mg/ml LPS solution
around the gingival sulcus. The production of the
inflammatory mediators IL-1β  and TNF-α was
measured in the supernatants of the whole blood of
the periodontitis model after 4 hours ex vivo culture
with or without LPS secondary challenge.
Figure 1. TNF-α level of supernatant from ex vivo
whole blood culture of periodontitis model. a)
without and b) with 20ml of 100ng/ml LPS
secondary challenge.
Figure 1 showed TNF-α level between control and
the two treatment groups. Results showed no
significant difference between the study groups
(p=0.1045). However, TNF-α level measured in
supernatant of the 10µg/ml LPS group with second
LPS challenge showed the highest TNF-α level
compared to other groups. The high dose of LPS was
comparable to the low dose. Repeated measures
ANOVA also showed that pairing were not effectively
significant. Therefore, there was no difference of
TNF-α level from the supernatant between culture
with and without LPS secondary challenge in all study
groups (p=1.223). This finding was similar to the
research done by Fokkema, et al. [11]. That study
showed that there was no difference on TNF-α level
in whole blood culture between periodontitis
patients and control indicating that the peripheral
blood cells of patients with periodontitis showed a
similar competence as control subjects to produce
these latter cytokines. The relationship between
clinical parameters and concentrations of the pro-
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inflammatory cytokines  is important in the initiation
and progression of periodontal disease, within
inflamed gingival tissues and serum samples from
patients with severe chronic periodontitis16.
Preliminary study done by Queiroz et al. showed
that the concentrations of IL-1β, TNF-α, IL-2, IFN-γ
were, on average, significantly higher in serum
samples and gingival tissue biopsies from
periodontitis patients than in healthy controls.
However, there was no association between cytokine
concentrations and clinical parameters of
periodontitis was found since serum samples from
both groups showed high individual variability of
cytokine profiles17.
production (p<0.05) (Figure 2). There was no
significant difference between control and high dose
of of LPS. High dose of LPS can be lethal, however,
some studies have shown that repeated application
of endotoxin can reduce immune response. This
phenomenon is firstly investigated by Beeson and
referred as endotoxin tolerance18.
Interleukin-1 beta (IL-1β) and Tumor Necrosis
Factor alpha (TNF-α) are involved in Th1 immune
responses and induce mainly cell-mediated
immunity16. LPS-induced cytokine expression is via a
pathogen ligand called toll-like receptors (TLRs). TLRs
trigger a cascade of signaling pathways leading to the
activation of NF-κB, which in turn activates the
expression of cytokine genes, including IL-1β, TNF-
α, and IL-6. TLR4 is a predominant signaling receptor
in human whole blood. TLR4, but not TLR2,
contributes in mediating cellular activation in
response to E. coli LPS19. However, Faure, et al. shown
that E. coli LPS also induces TLR2 expression in human
endothelial cells20.
Secondary challenge of LPS in ex vivo whole blood
culture showed no differences compared to culture
without LPS challenge. This findings contrasts to
some studies that showed the reduction of serum
level of TNF-α in the animal groups receiving
repeated injection of LPS compared with the groups
that only received a single dose of LPS10. The ex vivo
challenge of 1µg/ml E. coli LPS into the whole blood
collected from mice, twenty four hour after i.v.
injection 100µg of E. coli,  have resulted in a
significant decrease of TNF-α level from cells
supernatants21.  This discrepancy may due to the
application method of in vivo LPS initial challenge in
periodontitis model. In this experiment, LPS was
topically applied onto the periodontal tissues,
whereas some previous studies applied the LPS by
directly injected into the body system. Only some of
thick slurry LPS applied onto the gingival tissue was
able to penetrete deeper tissues and this took more
time than injection method. The time taken for
mimicking periodontitis model were 2 weeks, that
might not sufficient to induce or impair immune
response. These difference methods affected the
immune response thus failed to prove the existence
of endotoxin tolerance phenomenon.
Figure 2. IL-1β level of supernatant from ex vivo
whole blood culture of periodontitis model. a)
without and b) with 20µl of 100ng/ml LPS
secondary challenge.
* significant difference (p<0.05) compared to
control and 1mg/ml LPS groups.
IL-1β showed similar trend with the previous
cytokine with no significant matching between
supernatant with and without LPS secondary
challenge. However, low dose of LPS topical
application resulted in significant higher cytokine
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4. Conclusion
Periodontitis model in rats done by the combination
of ligature insertion and LPS topical application
change the trend of IL-1β and TNF-α production. This
experiment, once again, proved the contribution of
periodontal disease in the pathogenesis of systemic
diseases. Further study needs to be done to
investigate close relationship between periodontal
and systemic disease.
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